Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The injectable medicine, sold and patented by Eli Lilly and Company, contains the active ingredient tirzepatide, which was first approved under the brand name Mounjaro in May 2022 to improve glycemic control in people with Type 2 diabetes
The FDA approved a further step to 2 mg weekly in March 2022 for patients who require more intensive A1C lowering 2
By stabilizing energy levels, the medication helps reduce emotional eating, binge urges, and overeating triggered by blood sugar swings
Remove it from the refrigerator about 15-30 minutes before injection
This advanced formula helps promote efficient fat burning, maintain healthy cholesterol levels, and provide powerful antioxidant protection for enhanced metabolic health
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 26.12
US$ 28.91
US$ 28.83
US$ 21.46
US$ 26.88
